Maravai Lifesciences Holdings (MRVI) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $0.68.
- Maravai Lifesciences Holdings' Debt to Equity fell 2037.17% to $0.68 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.68, marking a year-over-year decrease of 2037.17%. This contributed to the annual value of $0.51 for FY2024, which is 2273.74% down from last year.
- As of Q3 2025, Maravai Lifesciences Holdings' Debt to Equity stood at $0.68, which was down 2037.17% from $0.63 recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' Debt to Equity registered a high of $2.54 during Q1 2021, and its lowest value of $0.51 during Q4 2024.
- Over the past 5 years, Maravai Lifesciences Holdings' median Debt to Equity value was $0.68 (recorded in 2025), while the average stood at $0.94.
- In the last 5 years, Maravai Lifesciences Holdings' Debt to Equity crashed by 6028.25% in 2021 and then surged by 4473.32% in 2024.
- Maravai Lifesciences Holdings' Debt to Equity (Quarter) stood at $1.37 in 2021, then plummeted by 57.54% to $0.58 in 2022, then increased by 13.89% to $0.66 in 2023, then fell by 22.74% to $0.51 in 2024, then surged by 32.25% to $0.68 in 2025.
- Its last three reported values are $0.68 in Q3 2025, $0.63 for Q2 2025, and $0.56 during Q1 2025.